Log In
Print
BCIQ
Print
Print this Print this
 

Entyvio, vedolizumab (MLN0002)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionHumanized mAb against integrin alpha(4)beta(7)
Molecular Target Integrin alpha(4)beta(7)
Mechanism of ActionBinds integrin alpha(4)beta(7); Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today